This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Benzinga12/30 20:54

Despite Lacking Profits Arcutis Biotherapeutics (NASDAQ:ARQT) Seems To Be On Top Of Its Debt

Simply Wall St12/30 20:20

Arcutis Biotherapeutics Price Target Announced at $19.00/Share by HC Wainwright & Co.

Dow Jones12/30 20:04

Arcutis Biotherapeutics Analyst Ratings

Benzinga12/30 19:52

Top-rated Smaller Defensive Stocks After Societe Generale Permabear Takes Contrarian View

Seeking Alpha12/28 22:00

What Awaits These 4 Biotech Stocks That More Than Doubled in 2024

Zacks 12/26 22:40